SHP2 inhibition displays efficacy as a monotherapy and in combination with JAK2 inhibition in preclinical models of myeloproliferative neoplasms
Article in American Journal of Hematology (March 2024)
The most recent citing publications are shown below. View all 27 publications that cite this research output on Dimensions.
Article in American Journal of Hematology (March 2024)
Article in Frontiers in Immunology (March 2024)
Article in Iranian Journal of Basic Medical Sciences (January 2024)